A chronic bioluminescent model of experimental visceral leishmaniasis for accelerating drug discovery

Imaging visceral leishmaniasis in real time with golden hamster model: Monitoring the parasite burden and hamster transcripts to further characterize the immunological responses of the host

(2017) Eline Rouault et al.   PARASITOLOGY INTERNATIONAL

New insights into experimental visceral leishmaniasis: Real-time in vivo imaging of Leishmania donovani virulence

(2017) Guilherme D. Melo et al.   PLoS Neglected Tropical Diseases

Drug resistance and treatment failure in leishmaniasis: A 21st century challenge

(2017) Alicia Ponte-Sucre et al.   PLoS Neglected Tropical Diseases

Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial

(2016) Monique Wasunna et al.   PLoS Neglected Tropical Diseases

Trypanosomatids see the light: recent advances in bioimaging research

(2015) Estefanía Calvo-Álvarez et al.   DRUG DISCOVERY TODAY

Lessons from other diseases: granulomatous inflammation in leishmaniasis

(2015) Paul M. Kaye et al.   Seminars in Immunopathology

A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis

(2015) Emily Rose Mears et al.   PLoS Neglected Tropical Diseases

Generation of Luciferase-Expressing Leishmania infantum chagasi and Assessment of Miltefosine Efficacy in Infected Hamsters through Bioimaging

(2015) Juliana Q. Reimão et al.   PLoS Neglected Tropical Diseases

Infrared Fluorescent Imaging as a Potent Tool for In Vitro, Ex Vivo and In Vivo Models of Visceral Leishmaniasis

(2015) Estefanía Calvo-Álvarez et al.   PLoS Neglected Tropical Diseases

Characterization of Metabolically Quiescent Leishmania Parasites in Murine Lesions Using Heavy Water Labeling

(2015) Joachim Kloehn et al.   PLoS Pathogens

Bioluminescence imaging of chronicTrypanosoma cruziinfections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection

(2014) Michael D. Lewis et al.   CELLULAR MICROBIOLOGY

An update on pharmacotherapy for leishmaniasis

(2014) Shyam Sundar et al.   EXPERT OPINION ON PHARMACOTHERAPY

Leishmaniasis

(2014) David Pace   JOURNAL OF INFECTION

Visceral Leishmaniasis and HIV Co-infection in Bihar, India: Long-term Effectiveness and Treatment Outcomes with Liposomal Amphotericin B (AmBisome)

(2014) Sakib Burza et al.   PLoS Neglected Tropical Diseases

Five-Year Field Results and Long-Term Effectiveness of 20 mg/kg Liposomal Amphotericin B (Ambisome) for Visceral Leishmaniasis in Bihar, India

(2014) Sakib Burza et al.   PLoS Neglected Tropical Diseases

Target-based vs. phenotypic screenings in Leishmania drug discovery: A marriage of convenience or a dialogue of the deaf?

(2014) Rosa M. Reguera et al.   International Journal for Parasitology-Drugs and Drug Resistance

Epidemiology of visceral leishmaniasis

(2014) Paul Ready   Clinical Epidemiology

Increasing Failure of Miltefosine in the Treatment of Kala-azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance

(2013) Suman Rijal et al.   CLINICAL INFECTIOUS DISEASES

Programmed Death 1-Mediated T Cell Exhaustion during Visceral Leishmaniasis Impairs Phagocyte Function

(2013) K. J. Esch et al.   JOURNAL OF IMMUNOLOGY

CD8 T Cell Exhaustion in Human Visceral Leishmaniasis

(2013) Shalini Gautam et al.   JOURNAL OF INFECTIOUS DISEASES

Leishmaniasis: clinical syndromes and treatment

(2013) B. S. McGwire et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Highly Sensitive In Vivo Imaging of Trypanosoma brucei Expressing “Red-Shifted” Luciferase

(2013) Alex P. McLatchie et al.   PLoS Neglected Tropical Diseases

Efficacy of Miltefosine in the Treatment of Visceral Leishmaniasis in India After a Decade of Use

(2012) S. Sundar et al.   CLINICAL INFECTIOUS DISEASES

Efficacy and tolerability of oleylphosphocholine (OlPC) in a laboratory model of visceral leishmaniasis

(2012) A. Fortin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Leishmaniasis Worldwide and Global Estimates of Its Incidence

(2012) Jorge Alvar et al.   PLoS One

T cell exhaustion in protozoan disease

(2012) Jason P. Gigley et al.   TRENDS IN PARASITOLOGY

Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial

(2012) Ahmed Musa et al.   PLoS Neglected Tropical Diseases

Impact of Continuous Axenic Cultivation in Leishmania infantum Virulence

(2012) Diana Moreira et al.   PLoS Neglected Tropical Diseases

Quantitative proteome profiling informs on phenotypic traits that adapt Leishmania donovani for axenic and intracellular proliferation

(2011) Pascale Pescher et al.   CELLULAR MICROBIOLOGY

Combination therapy for visceral leishmaniasis

(2011) Johan van Griensven et al.   LANCET

Bright and stable near-infrared fluorescent protein for in vivo imaging

(2011) Grigory S Filonov et al.   NATURE BIOTECHNOLOGY

Luciferase-Expressing Leishmania infantum Allows the Monitoring of Amastigote Population Size, In Vivo, Ex Vivo and In Vitro

(2011) Grégory Michel et al.   PLoS Neglected Tropical Diseases

Red-emitting luciferases for bioluminescence reporter and imaging applications

(2009) Bruce R. Branchini et al.   ANALYTICAL BIOCHEMISTRY

Mammalian Expression of Infrared Fluorescent Proteins Engineered from a Bacterial Phytochrome

(2009) X. Shu et al.   SCIENCE

Imaging Leishmania development in their host cells

(2009) Thierry Lang et al.   TRENDS IN PARASITOLOGY

B7-H1 Blockade Increases Survival of Dysfunctional CD8+ T Cells and Confers Protection against Leishmania donovani Infections

(2009) Trupti Joshi et al.   PLoS Pathogens